|

Ara-C Group Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • The First Affiliated Hospital of Soochow University1

Indications

  • Consolidation Therapy1
  • Hematopoietic Stem Cell Transplant (HSCT)1
  • High Risk1
  • Venentoclax1
  • Acute Myeloid Leukemia1

Other1 trial

Venetoclax Combined With Azacitidine for Consolidation Therapy in AML
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.